Telomere Stack

The Telomere Stack is a focused two-peptide protocol targeting chromosomal maintenance and cellular rejuvenation. Epithalon''s primary mechanism is activation of the catalytic subunit of telomerase (hTERT), the enzyme responsible for adding TTAGGG repeats to chromosome ends. In cell culture studies, Epithalon-treated fibroblasts showed a 33% increase in telomere length and extended their replicative lifespan by approximately 10 additional cell divisions beyond the Hayflick limit. In Khavinson''s longitudinal human studies, elderly patients receiving Epithalon showed normalized melatonin production, improved immune markers, and reduced all-cause mortality compared to controls over 6-12 year follow-up periods. GHK-Cu contributes to this stack through its remarkable gene expression modulation profile. Genome-wide studies reveal that GHK-Cu resets expression of numerous aging-related genes toward youthful patterns, including genes involved in DNA repair (GADD45A, XRCC1), antioxidant defense (SOD3, glutathione peroxidase), and anti-inflammatory pathways (IL-6 suppression, TGF-beta modulation). This transcriptomic "resetting" effect complements Epithalon''s telomere maintenance by ensuring that cells with preserved telomere length also maintain youthful functional capacity rather than persisting in a senescent-adjacent state. The stack follows a cyclical protocol: Epithalon is administered daily for 10 days, then discontinued for 4-6 months while GHK-Cu continues daily. This cycling is based on Khavinson''s research showing that telomerase activation occurs during the treatment window and persists for months afterward, making continuous administration unnecessary. GHK-Cu provides ongoing cellular maintenance between Epithalon cycles. This is one of the more conservative longevity stacks, suitable for individuals who want to address cellular aging biomarkers with well-characterized peptides.